N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: An active, low-toxicity regimen for metastatic harmonally unresponsive prostate cancer

Journal of Clinical Oncology

Volumn 13, Issue 6, 1995, Pages 1398-1403

  Brandes, L J ^a   Bracken, S P ^a   Ramsey, E W ^a  

^a Manitoba Cancer Treatment and Research Foundation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOPHOSPHAMIDE; HISTAMINE RECEPTOR; TESMILIFENE;

ADULT; AGED; ARTICLE; ATAXIA; BONE MARROW TOXICITY; BONE PAIN; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BLOCKING; VOMITING;

EID: 0029030798     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.6.1398     Document Type: Article

References (0)